This article explores dietary strategies to help prevent and manage cancer. It highlights foods to limit, such as processed meats and refined sugars, and recommends nutrient-rich options like olive oil, garlic, and broccoli. Additionally, it discusses key cancer therapies including Venclexta and Nerlynx, emphasizing the role of nutrition alongside medical treatments for better health outcomes.

Optimizing nutrition is crucial for maintaining overall well-being and decreasing the risk of cancer. Making thoughtful dietary choices can strengthen the immune system and alleviate symptoms in conditions such as chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). While no specific diet can cure cancer, healthcare professionals recommend consuming foods that bolster immunity. Incorporating such nutrient-rich options may help in symptom management and support daily health.

Foods to Limit for Lower Cancer Risk

Reduce intake of:

Red and processed meats
Meats like sausages, ham, and beef jerky often contain preservatives linked to higher risks of colorectal and stomach cancers.

Alcohol
Excessive alcohol intake is connected with increased risks of cancers of the mouth, throat, esophagus, breast, liver, stomach, and intestines, though effects differ by individual.

Refined carbs and sugars
Frequent consumption of foods high in refined sugars and carbohydrates can contribute to type 2 diabetes, inflammation, and oxidative damage.

Foods to Encourage for Cancer Prevention

Include these foods to reduce cancer risk:

Olive oil
Rich in antioxidants such as oleocanthal, olive oil helps combat oxidative stress and supports heart health, potentially lowering cancer risks.

Garlic
The compound allicin in garlic exhibits anti-cancer properties, especially reducing risks of stomach and prostate cancers.

Broccoli
Containing glucosinolates, broccoli activates detoxification enzymes, decreasing the likelihood of breast, prostate, and lung cancers.

Medical Therapies

Popular cancer treatments include:

Venclexta® (venetoclax)
This drug targets cancer cell proteins to enhance chemotherapy outcomes, particularly effective in adult patients with CLL or SLL when used alongside other treatments.

Nerlynx® (neratinib)
Designed for HER2-positive metastatic breast cancer, this kinase inhibitor provides targeted therapy for both early and advanced stages.